1. Home
  2. GBTG vs LEGN Comparison

GBTG vs LEGN Comparison

Compare GBTG & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Global Business Travel Group Inc.

GBTG

Global Business Travel Group Inc.

HOLD

Current Price

$9.40

Market Cap

4.9B

Sector

Technology

ML Signal

HOLD

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

HOLD

Current Price

$29.91

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GBTG
LEGN
Founded
2014
2014
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
5.9B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
GBTG
LEGN
Price
$9.40
$29.91
Analyst Decision
Buy
Strong Buy
Analyst Count
6
12
Target Price
$8.92
$61.33
AVG Volume (30 Days)
3.2M
3.2M
Earning Date
05-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
173.33
N/A
EPS
0.10
N/A
Revenue
$2,718,000,000.00
N/A
Revenue This Year
$21.78
$42.68
Revenue Next Year
$4.29
$30.52
P/E Ratio
$94.00
N/A
Revenue Growth
12.17
N/A
52 Week Low
$4.96
$16.24
52 Week High
$9.54
$45.30

Technical Indicators

Market Signals
Indicator
GBTG
LEGN
Relative Strength Index (RSI) 69.64 49.49
Support Level $9.33 $24.94
Resistance Level $9.46 $33.90
Average True Range (ATR) 0.04 1.66
MACD -0.06 -0.60
Stochastic Oscillator 68.18 26.87

Price Performance

Historical Comparison
GBTG
LEGN

About GBTG Global Business Travel Group Inc.

Global Business Travel Group Inc operates as a business-to-business travel platform. It is engaged in providing software and services to manage travel, expenses, and meetings and events for companies of all sizes. The company is engaged in building the marketplace in B2B travel to deliver unrivaled choice, value, and experiences. It also provides business travel solutions, simplified travel management, and business consulting services. Further, The company generates revenue in two ways that involves fees and other revenues relating to processing and servicing travel transactions received from clients and travel suppliers and revenues for the provision of products and professional services not directly related to transactions received from clients, travel suppliers and Network Partners.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: